WINNIPEG, MANITOBA--(Marketwire - April 14, 2011) - DiaMedica (TSX VENTURE:DMA) announced today that its Board of Directors has adopted a...
WINNIPEG, MANITOBA -- (Marketwire) -- 04/14/11 -- DiaMedica (TSX VENTURE: DMA) announced today that its Board of Directors has adopted a...
WINNIPEG, MANITOBA--(Marketwire - April 11, 2011) - DiaMedica (TSX VENTURE:DMA) is pleased to announce the company's entry into an evaluation...
WINNIPEG, MANITOBA -- (Marketwire) -- 04/11/11 -- DiaMedica (TSX VENTURE: DMA) is pleased to announce the company's entry into an evaluation...
WINNIPEG, MANITOBA -- (Marketwire) -- 03/02/11 -- DiaMedica (TSX VENTURE: DMA) today announces antihypertensive results with its lead monoclonal...
WINNIPEG, MANITOBA--(Marketwire - March 2, 2011) - DiaMedica (TSX VENTURE:DMA) today announces antihypertensive results with its lead monoclonal...
WINNIPEG, MANITOBA -- (Marketwire) -- 01/26/11 -- DiaMedica (TSX VENTURE: DMA) is pleased to announce preliminary results of its influenza program...
WINNIPEG, MANITOBA--(Marketwire - Jan. 26, 2011) - DiaMedica (TSX VENTURE:DMA) is pleased to announce preliminary results of its influenza program...
WINNIPEG, MANITOBA -- (Marketwire) -- 01/17/11 -- DiaMedica (TSX VENTURE: DMA) today announces data from its monoclonal antibody (mAb) program...
WINNIPEG, MANITOBA--(Marketwire - Jan. 17, 2011) - DiaMedica (TSX VENTURE:DMA) today announces data from its monoclonal antibody (mAb) program...
WINNIPEG, MANITOBA -- (Marketwire) -- 12/28/10 -- DiaMedica (TSX VENTURE: DMA) today announces, that pursuant to the provision of written...
WINNIPEG, MANITOBA--(Marketwire - Dec. 28, 2010) - DiaMedica (TSX VENTURE:DMA) today announces, that pursuant to the provision of written...
WINNIPEG, MANITOBA -- (Marketwire) -- 11/22/10 -- DiaMedica (TSX VENTURE: DMA) today announces that in accordance with the terms of the warrant...
WINNIPEG, MANITOBA--(Marketwire - Nov. 22, 2010) - DiaMedica (TSX VENTURE:DMA) today announces that in accordance with the terms of the warrant...
WINNIPEG, MANITOBA -- (Marketwire) -- 11/08/10 -- DiaMedica Inc., (TSX VENTURE: DMA) is pleased to announce the commencement of a research...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.